Ignite Creation Date:
2024-05-06 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05271630
Status:
RECRUITING
Last Update Posted:
2024-02-14
First Post:
2022-02-28
Brief Title:
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Sponsor:
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Minimal Residual Disease MRD testing by Clonoseq will be performed in the peripheral blood of the patients at the same time points that MRD testing will be done in the bone marrow in addition to at 6 and 18 months
Investigators will examine the impact gut microbiota on MRD status and racial ethnic differences in study population Stool samples will be collected at baseline and 1- and 2-years post Autologous Stem Cell Transplant
Enrollment Count:
69
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 83765 |
Who Masked List: